Accelerating Open Biomedical Research


Sage Bionetworks is a non-profit research organization that seeks to develop predictors of disease and accelerate health research through the creation of open systems, incentives, and standards. We create strategies and platforms that empower researchers to share and interpret data on a colossal scale, crowdsource tests for new hypotheses, and contribute to knowledge  through community challenges.

Current at Sage

Sage Bionetworks, in a broad partnership led by OHSU, has been awarded the new CTSA Program National Center for Data to Health (CD2H). This award will coalesce and coordinate informatics activities across the Clinical and Translational Science Award (CTSA) Program, a network of more than 50 medical research institutions, to provide collaborative clinical and translational research infrastructure.
Sage Bionetworks and the Institute for Systems Biology will partner to build the Cancer Research Institute iAtlas, an online database and web resource designed to help basic and clinical researchers navigate immunological data across multiple tumor types. The CRI iAtlas database is the first comprehensive effort in immuno-oncology to address the recent National Cancer Moonshot Blue Ribbon Panel recommendation to establish a pan-cancer immune atlas that would help catalyze new research in cancer immunotherapy.
A new cancer neoantigen discovery alliance led by the Parker Institute for Cancer Immunotherapy and the Cancer Research Institute is bringing together 30 leading research groups to help develop more effective personalized cancer vaccines for patients faster. Sage Bionetworks will lead the bioinformatics and data analysis effort.
As part of the most ambitious medical research program in the history of American medicine, The Scripps Research Institute (TSRI) and its partners including Sage Bionetworks have received an initial award of $20M for their role in President Obama’s national All of Us Research Program. This landmark longitudinal research effort will leverage smart phones and other personal technologies to engage one million or more U.S. participants to improve the ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.


February 15, 2018

Nature Communications shares results of a multicenter study revealing sepsis patients can be risk stratified at the time of diagnosis, demonstrating potential to improve critical care medicine on a global scale. Full Article

January 17, 2018

Sage Bionetworks and MJFF announce the winners of the PD Digital Biomarker DREAM Challenge, the first to use remote sensor data to diagnose and track Parkinson’s disease. Full Article

November 3, 2017

Sage Bionetworks is part of a consortium of universities and research groups which has received a five-year, $25 million grant from the National Center for Advancing Translational Science Full Article

August 21, 2017

Novartis launches elevateMS developed together with Sage – the first large-scale research study in MS allowing participants to contribute from smartphones Full Article

Work with us.

Sage was recently ranked as the 2nd best place to work in academia. We invite you to make an impact on research and technology by being a part of our integrated group of computational biologists, clinicians, and software engineers . MORE

Sage Bionetworks’ Current Funding Partners include: